← All trials
NCT04761731
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 31, 2015
- Primary completion
- Dec 14, 2017
- Completion date
- Dec 14, 2017
- First posted
- Feb 21, 2021
- Last posted
- Feb 21, 2021
- Enrollment
- 31
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Linical Co., Ltd.Lead sponsor
- AstellasCollaborator
- National Cancer Center, KoreaOverall official - principal investigator
- National Cancer Center, KoreaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.